Literature DB >> 8307780

Comparison of 3' and 5' biotin labelled oligonucleotides for in situ hybridisation.

P G Bardin1, M A Pickett, S B Robinson, G Sanderson, S T Holgate, S L Johnston.   

Abstract

Oligonucleotide probes enzymatically labelled at the 3'-end with biotin have been used successfully to detect target RNA and DNA in combination with in situ hybridisation. Addition of multiple biotin residues to the 3'-end increases the hybridisation signals, but it is not known whether the same principle is applicable to the 5'-end. We have labelled a 35-base oligonucleotide during synthesis with 1, 5 and 12 biotin molecules at the 5'-end and compared it to conventional 3'-labelling. In additional experiments the probes were labelled at both ends. Probes were applied to histological sections obtained from paraffin-embedded cell-clot-complexes that contain uninfected and Rhinoviral-infected cells, using a standard in situ hybridisation protocol with appropriate controls. Hybridisation signals were compared for intensity of cytoplasmic signal and sensitivity as number of positive cells. Both parameters increased in parallel with higher numbers of biotin residues attached to the 5'-end and 12 biotin residues were almost as effective as 3'-enzymatic tailing. The sensitivity could be increased above that of either 3'- or 5'-labelling by the addition of residues at both ends of the probe. The 5'-attachment of biotin residues can extend the value of oligonucleotide probes employed for in situ hybridisation and yield increased sensitivity when combined with 3'-enzymatic labelling.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8307780     DOI: 10.1007/BF00268937

Source DB:  PubMed          Journal:  Histochemistry        ISSN: 0301-5564


  18 in total

1.  Detection of Epstein-Barr virus by in situ hybridization. Progress toward development of a nonisotopic diagnostic test.

Authors:  R Bashir; F Hochberg; R H Singer
Journal:  Am J Pathol       Date:  1989-12       Impact factor: 4.307

2.  Multiple fluorescence in situ hybridization.

Authors:  P M Nederlof; S van der Flier; J Wiegant; A K Raap; H J Tanke; J S Ploem; M van der Ploeg
Journal:  Cytometry       Date:  1990

3.  In situ hybridization demonstration of poly-adenylated RNA sequences in formalin-fixed paraffin sections using a biotinylated oligonucleotide poly d(T) probe.

Authors:  J H Pringle; L Primrose; C N Kind; I C Talbot; I Lauder
Journal:  J Pathol       Date:  1989-08       Impact factor: 7.996

4.  Immunological method for mapping genes on Drosophila polytene chromosomes.

Authors:  P R Langer-Safer; M Levine; D C Ward
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

5.  Chemical and enzymatic biotin-labeling of oligodeoxyribonucleotides.

Authors:  T Kempe; W I Sundquist; F Chow; S L Hu
Journal:  Nucleic Acids Res       Date:  1985-01-11       Impact factor: 16.971

6.  Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions.

Authors:  R F Lemanske; E C Dick; C A Swenson; R F Vrtis; W W Busse
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

7.  Synthesis and hybridization of a series of biotinylated oligonucleotides.

Authors:  A F Cook; E Vuocolo; C L Brakel
Journal:  Nucleic Acids Res       Date:  1988-05-11       Impact factor: 16.971

8.  Histochemical detection of the messenger RNAs coding for calcitonin and calcitonin gene-related peptide in medullary thyroid carcinomas with radioactive and biotinylated oligonucleotide probes.

Authors:  C Mougin; A F Guitteny; B Fouque; G Viennet; R Teoule; B Bloch
Journal:  J Pathol       Date:  1990-03       Impact factor: 7.996

9.  Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene.

Authors:  C Le Moine; E Normand; B Bloch
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

Review 10.  Viruses as precipitants of asthma symptoms. I. Epidemiology.

Authors:  P K Pattemore; S L Johnston; P G Bardin
Journal:  Clin Exp Allergy       Date:  1992-03       Impact factor: 5.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.